Our experts and projects
Our COVID-19 experts and projects
With more than 25 of our science leaders applying their expertise to respond to COVID-19, we are at the forefront of efforts to understand the coronavirus and protect our communities.
Our projects aim to provide a deep understanding of the immune response, contribute to the development of antivirals and vaccines, inform how we can respond to the pandemic, and understand and eliminate disease complications in COVID-19 patients.
Explore our research projects within the following research themes:
-
1. Understanding the coronavirus and how to stop it
Working towards the discovery of antiviral therapies, effective vaccines and treatments
A plug-and-go vaccine platform for the development of rapid vaccines
Structure-based design of SARS CoV-2 drugs and vaccine antigens
Alternative CPAP and oxygen delivery systems for COVID19 patients
Cell-based approaches for treatment of lung disease
-
In-depth characterisation of the body's immune response to the virus to aid patient recovery
Measuring how our immune system responds during SARS-COV2/COVID19 infection
Modulators of immune signalling in cytokine storm arising from COVID-19
Inhibitors of immune effectors to combat immune driven disease in COVID-19
Immune response to SARS-CoV-2
Novel antibodies targeting proteins encoded by the SARS-CoV-2 genome
Investigating the dendritic cell response to SARS-CoV-2
Evolutionary studies of SARS-CoV-2
Gamma delta T cell immune response to COVID-19
Approaches to treat clotting pathologies in relation to late stage COVID-19
-
2. Informing our response to the pandemic
Novel antibodies targeting proteins encoded by the SARS-CoV-2 genome
Improvement of CRISPR-Cas13a RNA detection for COVID-19 diagnosis
Evolutionary studies of SARS-CoV-2
-
3. Understanding co-morbidities and complications
Approaches to treat clotting pathologies in relation to late stage COVID-19
Inhibitors of immune effectors to combat immune driven disease in COVID-19
Novel antibodies targeting proteins encoded by the SARS-CoV-2 genome
Cell-based approaches for treatment of lung disease
Evolutionary studies of SARS-CoV-2
-